Financials uniQure N.V.

Equities

QURE

NL0010696654

Biotechnology & Medical Research

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
4.53 USD -0.22% Intraday chart for uniQure N.V. -3.00% -33.09%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,731 1,316 843 991.7 293.3 205.8 - -
Enterprise Value (EV) 1 2,425 1,143 438.9 873.5 180.7 150 155 -19.82
P/E ratio -22.9 x -12.7 x 2.92 x -8.25 x -1.03 x -1.05 x -1.2 x -1.41 x
Yield - - - - - - - -
Capitalization / Revenue 418 x 42.5 x 1.81 x 9.83 x 20.1 x 3.7 x 2.63 x 1.7 x
EV / Revenue 371 x 36.9 x 0.94 x 8.65 x 12.4 x 2.7 x 1.98 x -0.16 x
EV / EBITDA -23.6 x -12 x 1.56 x -6.85 x -0.72 x -0.91 x -1.15 x 0.2 x
EV / FCF -25.9 x -9.7 x 1.83 x -5.69 x -1.28 x -0.77 x -0.88 x 0.14 x
FCF Yield -3.86% -10.3% 54.7% -17.6% -78.2% -130% -113% 714%
Price to Book 8.82 x 6.5 x 1.6 x 2.21 x 1.53 x 4.78 x -3.04 x -
Nbr of stocks (in thousands) 42,731 44,496 46,214 46,815 47,810 48,503 - -
Reference price 2 63.92 29.58 18.24 21.18 6.134 4.243 4.243 4.243
Announcement Date 3/2/20 3/1/21 2/25/22 2/27/23 2/28/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 6.531 31.01 465.1 100.9 14.6 55.57 78.26 121.1
EBITDA 1 -102.7 -95.19 282.2 -127.6 -249.7 -165 -134.4 -98.2
EBIT 1 -108.7 -103.7 275.7 -135.7 -260.7 -185.1 -159.7 -138.3
Operating Margin -1,663.78% -334.34% 59.28% -134.44% -1,785.46% -333.04% -204.07% -114.15%
Earnings before Tax (EBT) 1 -111.4 -117.3 295.4 -121.6 -282.5 -205.3 -193.4 -166
Net income 1 -111.4 -103.7 292.5 -120.2 -284.3 -202.4 -182.1 -161
Net margin -1,705.82% -334.4% 62.9% -119.07% -1,947.09% -364.17% -232.74% -132.95%
EPS 2 -2.790 -2.322 6.249 -2.569 -5.962 -4.023 -3.542 -3.010
Free Cash Flow 1 -93.59 -117.8 240.1 -153.6 -141.3 -195.7 -175.8 -141.5
FCF margin -1,432.98% -380.07% 51.63% -152.21% -967.82% -352.23% -224.69% -116.86%
FCF Conversion (EBITDA) - - 85.09% - - - - -
FCF Conversion (Net income) - - 82.08% - - - - -
Dividend per Share 2 - - - - - - - -
Announcement Date 3/2/20 3/1/21 2/25/22 2/27/23 2/28/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 1.71 51.21 1.7 0.4894 1.468 97.38 4.833 2.198 1.317 6.164 5.819 7.729 21.58 26.12 14.34
EBITDA 1 -37.16 3.479 -49.45 -52.92 -58.21 27.33 -65.39 -56.99 -74.18 -53.04 -50.9 -50.16 -50.71 -52.19 -
EBIT 1 -38.69 1.836 -51.32 -55.2 -60.3 25.12 -67.32 -59.05 -76.23 -56.9 -52.02 -51.78 -34.68 -44.76 -35.6
Operating Margin -2,262.45% 3.58% -3,017.85% -11,279.79% -4,107.53% 25.79% -1,392.9% -2,686.79% -5,790.03% -923.13% -893.87% -670.02% -160.66% -171.38% -248.26%
Earnings before Tax (EBT) 1 -31.33 6.981 -44.88 -38.77 -48.82 6.255 -71.19 -61.99 -83.45 -64.66 -54.71 -51.03 -49.11 -36.85 -36.94
Net income 1 -31.41 7.285 -44.29 -38.46 -48.48 6.452 -70.09 -62.13 -83.39 -67.46 -55.69 -52.73 -51.53 -29.77 -36.94
Net margin -1,836.66% 14.23% -2,604.8% -7,859.29% -3,302.77% 6.63% -1,450.27% -2,827.17% -6,334.12% -1,094.42% -957.06% -682.23% -238.75% -113.96% -257.58%
EPS 2 -0.6792 0.1509 -0.9489 -0.8271 -1.033 0.1422 -1.479 -1.307 -1.750 -1.410 -1.173 -1.119 -1.096 -0.7678 -0.9648
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 10/25/21 2/25/22 5/2/22 8/8/22 11/2/22 2/27/23 5/9/23 8/1/23 11/7/23 2/28/24 - - - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 307 174 404 118 113 55.8 50.8 226
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 -93.6 -118 240 -154 -141 -196 -176 -142
ROE (net income / shareholders' equity) -49.4% -44.1% 78.5% -23.7% -90.2% -144% - -
ROA (Net income/ Total Assets) -34.4% -31.7% 57.3% - - - - -
Assets 1 324.1 327.2 510.2 - - - - -
Book Value Per Share 2 7.240 4.550 11.40 9.570 4.010 0.8900 -1.400 -
Cash Flow per Share - - - - - - - -
Capex 1 5.07 6.03 15.5 16.7 6.6 6 6.22 7.03
Capex / Sales 77.61% 19.45% 3.33% 16.54% 45.23% 10.8% 7.95% 5.81%
Announcement Date 3/2/20 3/1/21 2/25/22 2/27/23 2/28/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
4.243 EUR
Average target price
18.98 EUR
Spread / Average Target
+347.40%
Consensus
  1. Stock Market
  2. Equities
  3. QURE Stock
  4. Financials uniQure N.V.